iDayo Selects ACAD as Low Risk Investment

Call Now
800-993-0005

(^DJI) 0

0S&P 500 (^GSPC) 1295.22

-9.64NASDAQ Composite (^IXIC) 2778.79

-34.9Russell 2000 (^RUT) 747.21

iDayo™ Stock Selector: ACAD - Acadia Pharmaceuticals

iDayo™ 08/20/07: Acadia Pharmaceuticals (ACAD) - 08/20/07

For the 16 week investment period starting 08/20/07 , the iDayo™ Stock Selector rated Acadia Pharmaceuticals (ACAD) as "Significant Accumulation" and selected ACAD as a buy for the investment period, identified as iDayo™ 08/20/07.

Company Profile for "Acadia Pharmaceuticals (ACAD)": Acadia Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders

Google Finance History for ACAD

iDayo, Inc. (including its marketing professionals and staff), is not a registered Investment Advisor or Broker/Dealer, and does not provide investment advice or recommendations. Subscribers to iDayo™ are advised that the information, opinions, and analysis included in our web sites, on our free Educational Conference Calls, or in any other communication are based in good faith on sources believed to be reliable, but no representation or warranty, expressed or implied, is made as to their accuracy, completeness, or correctness.

Past performance is not necessarily indicative of the future performance of stocks posted. None of these postings, the iDayo™ system rating, nor any other information provided on our web sites, on our free Educational Conference Calls, or in any other communication constitutes a recommendation to buy or sell stocks or any other investment. Investing involves the risk of loss and Subscribers are urged to consult with their own independent financial advisors with respect to any investment.